Assessment Of Biliary Enteric Anastomosis In Benign Biliary Disorders
-
Published:2022-10-19
Issue:
Volume:
Page:396-398
-
ISSN:2229-7723
-
Container-title:Journal of Pharmaceutical Negative Results
-
language:
-
Short-container-title:Journal of Pharmaceutical Negative Results
Author:
Dr. Srilakshmi Vemulapalli ,Dr S J Bhosale ,Dr. Nandan Madhwapathy
Abstract
Background: To assess Biliary Enteric Anastomosis in Benign Biliary Disorders.Materials & methods: A total of 100 patients were evaluated. Only those patients were included which were affected by BBDundergoing biliary enteric anastomosis were enrolled. The procedures used were choledochoduodenostomy (CDD),choledochojejunostomy (CDJ), and Roux-en-Y hepaticojejunostomy (HJ). All the patients were pre-informed about the entire studyprotocol. Complete biochemical profile of all the patients was evaluated.Follow-up was done and occurrence of complications, if any,was recorded separately. All the results were recorded and analysed using SPSS software.Results: Out of 100 patients with BBD, Choledochoduodenostomy (CDD), Choledochojejunostomy (CDJ) and Roux-en-Yhepaticojejunostomy (HJ) were carried out in 41 percent, 29 percent and 30 percent of the patients respectively. While evaluating thecomplications, it was seen that leak and strictures were seen in 2 percent and 1 percent of the patients respectively.Cholangitis wasseen in 3 percent of the patients.On assessing the Uni-variate analysis for risk factors associated with complications, it was seen thatalbumin levels of less than 3.5 g/dL were significant risk factors for occurrence of complications.Conclusion: Biliary enteric anastomosis is a safe and effective method for the management of BBD
Subject
Drug Discovery,Pharmaceutical Science,Pharmacology